Viewing Study NCT03192202


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-01-29 @ 7:59 AM
Study NCT ID: NCT03192202
Status: COMPLETED
Last Update Posted: 2023-07-20
First Post: 2017-06-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: AFM13 in Relapsed/Refractory Cutaneous Lymphomas
Sponsor: Ahmed Sawas
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, T-Cell, Cutaneous View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None Cutaneous Lymphoma View
None cutaneous T-cell lymphoma (CTCL) View
None CD30-Positive Cutaneous Lymphoma View
None T-cell lymphoma View
None PTCL View
None CTCL View
None CD30 View
None immunotherapy View